CDC hails Merck's Rotateq for efficacy

Merck has yet another validation of its childhood vaccine Rotateq, designed to prevent rotavirus in infants and children: The CDC says the shot has led to a dramatic drop in hospitalization and ER visits since its debut two years ago, and even seems to be preventing illness in unvaccinated children. Report